GANT61 suppresses cell survival, invasion and epithelial-mesenchymal transition through inactivating AKT/mTOR and JAK/STAT3 pathways in anaplastic thyroid carcinoma
Glioma-associated oncogene (Gli) antagonist-61 (GANT61) not only suppresses the malignant behavior of several cancers but also presents synergistic effects with other anticancer agents on suppressing the progression of cancers, while relevant information is rare in anaplastic thyroid carcinoma (ATC)...
Gardado en:
| Principais autores: | , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Taylor & Francis Group
2022-12-01
|
| Series: | Cancer Biology & Therapy |
| Assuntos: | |
| Acceso en liña: | http://dx.doi.org/10.1080/15384047.2022.2051158 |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|